Kosin Med J.  2024 Dec;39(4):265-271. 10.7180/kmj.24.139.

Diagnostic significance of transcranial Doppler ultrasonography in patients with subarachnoid hemorrhage and cerebral vasospasm

• Park JH

• KMID: 2562810
• DOI: http://doi.org/10.7180/kmj.24.139

Abstract

Background
This study investigated the accuracy and usefulness of transcranial Doppler (TCD) ultrasonography as a diagnostic method in patients with subarachnoid hemorrhage (SAH) and cerebral vasospasm.
Methods
This retrospective study collected data from January 2022 to December 2023 at our institution, targeting patients with SAH caused by rupture of a cerebral aneurysm. TCD and brain computed tomographic angiography (CTA) were performed to diagnose cerebral vasospasm. The vessel diameters on CTA at the time of SAH occurrence and CTA 1 to 2 weeks after the occurrence were compared, and TCD was performed on a daily basis from 3 to 14 days after the occurrence of ictus.
Results
Among 152 patients with non-traumatic SAH over a 2-year period, 143 patients with SAH caused by ruptured cerebral aneurysms were enrolled. The mean age was 59.28±13.27 years. The modified Fisher grade was a statistically significant predictor of cerebral vasospasm (p<0.05). In addition, the Hunt-Hess grade also showed statistical significance (p<0.05). TCD showed high accuracy in predicting vasospasm. The sensitivity was 0.93 (95% confidence interval [CI], 0.87–0.97), specificity was 0.89 (95% CI, 0.81–0.96), positive predictive value was 0.92 (95% CI, 0.85–0.96), and negative predictive value was 0.92 (95% CI, 0.84–0.95).
Conclusions
TCD showed high accuracy in predicting the diagnosis of cerebral vasospasm. TCD is considered an essential diagnostic tool in the neurological management of cerebral vasospasm, which is a potentially fatal complication in SAH patients.

Keyword

Transcranial Doppler; Cerebral vasospasm; Subarachnoid hemorrhage

Reference

References

1. Lindbohm JV, Kaprio J, Jousilahti P, Salomaa V, Korja M. Sex, smoking, and risk for subarachnoid hemorrhage. Stroke. 2016; 47:1975–81.

2. Dorsch NW. Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care. 2002; 8:128–33.

3. Sarrafzadeh A, Haux D, Sakowitz O, Benndorf G, Herzog H, Kuechler I, et al. Acute focal neurological deficits in aneurysmal subarachnoid hemorrhage: relation of clinical course, CT findings, and metabolite abnormalities monitored with bedside microdialysis. Stroke. 2003; 34:1382–8.

4. Rabinstein AA, Friedman JA, Weigand SD, McClelland RL, Fulgham JR, Manno EM, et al. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke. 2004; 35:1862–6.

5. Suarez JI, Qureshi AI, Yahia AB, Parekh PD, Tamargo RJ, Williams MA, et al. Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: evaluation of transcranial Doppler ultrasound and cerebral angiography as related to compromised vascular distribution. Crit Care Med. 2002; 30:1348–55.

6. Naval NS, Thomas CE, Urrutia VC. Relative changes in flow velocities in vasospasm after subarachnoid hemorrhage: a transcranial Doppler study. Neurocrit Care. 2005; 2:133–40.

7. Silver B, Santalucia P, Benavides BA. Gender differences in vasospasm following subarachnoid hemorrhage: a transcranial Doppler study. J Neuroimaging. 1997; 7:239.

8. Ferguson S, Macdonald RL. Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 2007; 60:658–67.

9. Kumar G, Dumitrascu OM, Chiang CC, O’Carroll CB, Alexandrov AV. Prediction of delayed cerebral ischemia with cerebral angiography: a meta-analysis. Neurocrit Care. 2019; 30:62–71.

10. Charpentier C, Audibert G, Guillemin F, Civit T, Ducrocq X, Bracard S, et al. Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke. 1999; 30:1402–8.

11. van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007; 369:306–18.

12. Wilson DA, Nakaji P, Abla AA, Uschold TD, Fusco DJ, Oppenlander ME, et al. A simple and quantitative method to predict symptomatic vasospasm after subarachnoid hemorrhage based on computed tomography: beyond the Fisher scale. Neurosurgery. 2012; 71:869–75.

13. Chen J, Kathuria S, Gandhi D. Imaging evaluation and endovascular treatment of vasospasm. In : Quinones-Hinojosa A, editor. Schmidek and sweet operative neurosurgical techniques: indications, methods, and results. 6th ed. Elsevier Inc;2012. p. 1115–24.

14. Hollingworth M, Jamjoom AA, Bulters D, Patel HC. How is vasospasm screening using transcranial Doppler associated with delayed cerebral ischemia and outcomes in aneurysmal subarachnoid hemorrhage? Acta Neurochir (Wien). 2019; 161:385–92.

15. Lysakowski C, Walder B, Costanza MC, Tramer MR. Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: a systematic review. Stroke. 2001; 32:2292–8.

16. Blaumann OR, Grady PA, Nelson E. Hemodynamic and morphologic aspects of cerebral vasospasm. In : Price TR, Nelson E, editors. Cerebrovascular diseases. Raven Press;1970. p. 283–94.

17. van den Bergh WM, Algra A, van Kooten F, Dirven CM, van Gijn J, Vermeulen M, et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2005; 36:1011–5.

18. Lennihan L, Petty GW, Fink ME, Solomon RA, Mohr JP. Transcranial Doppler detection of anterior cerebral artery vasospasm. J Neurol Neurosurg Psychiatry. 1993; 56:906–9.

19. Qureshi AI, Sung GY, Suri MA, Straw RN, Guterman LR, Hopkins LN. Prognostic value and determinants of ultraearly angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 1999; 44:967–74.

20. Bornstein NM, Norris JW. Transcranial Doppler sonography is at present of limited clinical value. Arch Neurol. 1994; 51:1057–9.

21. Da Silva IR, Gomes JA, Wachsman A, de Freitas GR, Provencio JJ. Hematologic counts as predictors of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Crit Care. 2017; 37:126–9.

22. Burkhardt JK, Chen X, Winkler EA, Weiss M, Yue JK, Cooke DL, et al. Early hemodynamic changes based on initial color-coding angiography as a predictor for developing subsequent symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. World Neurosurg. 2018; 109:e363–73.

23. Zacharia BE, Hickman ZL, Grobelny BT, DeRosa P, Kotchetkov I, Ducruet AF, et al. Epidemiology of aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am. 2010; 21:221–33.

24. Siler DA, Gonzalez JA, Wang RK, Cetas JS, Alkayed NJ. Intracisternal administration of tissue plasminogen activator improves cerebrospinal fluid flow and cortical perfusion after subarachnoid hemorrhage in mice. Transl Stroke Res. 2014; 5:227–37.

25. Yundt KD, Grubb RL Jr, Diringer MN, Powers WJ. Autoregulatory vasodilation of parenchymal vessels is impaired during cerebral vasospasm. J Cereb Blood Flow Metab. 1998; 18:419–24.

26. Lindner SH, Bor AS, Rinkel GJ. Differences in risk factors according to the site of intracranial aneurysms. J Neurol Neurosurg Psychiatry. 2010; 81:116–8.

27. Cloft HJ, Joseph GJ, Dion JE. Risk of cerebral angiography in patients with subarachnoid hemorrhage, cerebral aneurysm, and arteriovenous malformation: a meta-analysis. Stroke. 1999; 30:317–20.

28. Saitoh H, Hayakawa K, Nishimura K, Okuno Y, Teraura T, Yumitori K, et al. Rerupture of cerebral aneurysms during angiography. AJNR Am J Neuroradiol. 1995; 16:539–42.

29. Beckmann U, Gillies DM, Berenholtz SM, Wu AW, Pronovost P. Incidents relating to the intra-hospital transfer of critically ill patients: an analysis of the reports submitted to the Australian Incident Monitoring Study in Intensive Care. Intensive Care Med. 2004; 30:1579–85.

30. Kyoi K, Hashimoto H, Tokunaga H, Morimoto T, Hiramatsu K, Tsunoda S, et al. Time course of blood velocity changes and clinical symptoms related to cerebral vasospasm and prognosis after aneurysmal surgery. No Shinkei Geka. 1989; 17:21–30.